SEC Form 4 · accession 0001179110-15-012119
MOMENTA PHARMACEUTICALS INC · MNTA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Franken
Officer — President, Biosimilars Busines
Period of report
Aug 10, 2015
Accepted (ET)
Aug 14, 2015 · 12:43 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001235010
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 10, 2015 | M | 20,000 | $17.23 | A | 59,001 | D | |
| Common Stock | Aug 10, 2015 | S | 20,000 | $22.36 | D | 39,001 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $17.23 | Aug 10, 2015 | M | 20,000 | A | Dec 10, 2014 | Dec 10, 2023 | Common Stock | 20,000 | 50,000 | D |